March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
March Biosciences has raised $200K in total funding. The most recent round was Grant. The last funding was announced in April 2025.
March Biosciences's investors include Modi Ventures, Mission BioCapital, 4BIO Capital, Portal Innovations, Alexandria Venture Investments.
March Biosciences is headquartered in Houston, United States.
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.
March Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"March Biosciences — Funding & Investors." VCBacked, April 29, 2025, https://www.vcbacked.co/company/march-biosciences. Accessed August 14, 2026.
VCBacked. (2025). March Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/march-biosciences
{{cite web |title=March Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/march-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated